Alseres Pharmaceuticals Inc

(ALSE)

By |

Profile

Alseres Pharmaceuticals Inc is a US-based biotechnology company. It is focused on the development of diagnostic and therapeutic products for disorders in the central nervous system. The company's lead product candidate is Altropane, a proprietary molecular imaging agent which is used to diagnose Parkinson's disease and dementia. Further, it is focused on entering into partnerships to ensure development and commercialization of its product. Geographically the firm carries out its business through the region of United States.

Contact Information

Website: www.alseres.com
Email: krice@alseres.com
Main Phone: +1 508 497-2360
Address: 275 Grove Street
Address 2: Suite 2-400
State: MA
City / Town: Auburndale
Country: USA
Postal Code: 02466

Issuer Information

Exchange: OTO
CEO: Peter G. Savas
Employees: 3
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Alseres Pharmaceuticals Inc is a US-based biotechnology company. It is focused on the development of diagnostic and therapeutic products for disorders in the central nervous system. The company's lead product candidate is Altropane, a proprietary molecular imaging agent which is used to diagnose Parkinson's disease and dementia. Further, it is focused on entering into partnerships to ensure development and commercialization of its product. Geographically the firm carries out its business through the region of United States.

Contact Information

Website: www.alseres.com
Email: krice@alseres.com
Main Phone: +1 508 497-2360
Address: 275 Grove Street
Address 2: Suite 2-400
State: MA
City / Town: Auburndale
Country: USA
Postal Code: 02466

Issuer Information

Exchange: OTO
CEO: Peter G. Savas
Employees: 3
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 6.00 $ 0. (0.00%)
Last Price 6.00 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 6.00
Last Trade Volume 0 52 Wk Hi 15.51 52 Wk Low 6.00
Market Cap 36,762 Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 6,127.00 EPS (TTM) -100.00 PE Ratio N/A Exchange OTCPK